GL1X · GenesisL1 explorer

Ligand · L7O

L7O · N-{5-[2-(methylamino)pyrimidin-4-yl]-2-oxo-1,2-dihydropyridin-3-yl}-4-(piperidin-1-yl)benzamide

L7O, N-{5-[2-(methylamino)pyrimidin-4-yl]-2-oxo-1,2-dihydropyridin-3-yl}-4-(piperidin-1-yl)benzamide (C22 H24 N6 O2, 404.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…

Component
L7O
Formula
C22 H24 N6 O2
Class
ligand
Structures
2
PDB entries
1

Binding sites

L7O in 2 structures; the first of them:

  • 3QGY · Crystal structure of ITK inhibitor complex · L7O B1 · binds ILE369, VAL377, ALA389, LYS391, GLU406, MET410, VAL419, PHE435 and 9 more
  • 3QGY · Crystal structure of itk inhibitor complex · L7O B1 · binds ILE369, VAL377, ALA389, LYS391, GLU406, MET410, VAL419, PHE435 and 9 more

Residues it binds most

GLU 2, MET 2, PHE 2, VAL 2, ALA 2, ASP 2, GLY 2, HIS 2, ILE 2, LEU 2 (residue and the binding sites it lines).

Found with

  • PQC · 3-[(8-phenylthieno[2,3-h]quinazolin-2-yl)amino]benzenesulfonamide

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.